Daniel Burdick

2.1k total citations · 1 hit paper
19 papers, 1.7k citations indexed

About

Daniel Burdick is a scholar working on Neurology, Physiology and Oncology. According to data from OpenAlex, Daniel Burdick has authored 19 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Neurology, 4 papers in Physiology and 3 papers in Oncology. Recurrent topics in Daniel Burdick's work include Parkinson's Disease Mechanisms and Treatments (4 papers), Neurological disorders and treatments (3 papers) and Biomedical Ethics and Regulation (2 papers). Daniel Burdick is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (4 papers), Neurological disorders and treatments (3 papers) and Biomedical Ethics and Regulation (2 papers). Daniel Burdick collaborates with scholars based in United States and United Kingdom. Daniel Burdick's co-authors include Christian J. Pike, CW Cotman, John T. Prior, Joseph V. Kosmoski, Brian Soreghan, Mary F. Knauer, Charles Glabe, Gerard T. Scanlon, James B. Leverenz and Cyrus P. Zabetian and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Neuroscience and Neurology.

In The Last Decade

Daniel Burdick

18 papers receiving 1.7k citations

Hit Papers

Neurodegeneration induced by beta-amyloid peptides in vit... 1993 2026 2004 2015 1993 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state
    1993 1.3k citations Christian J. Pike, Daniel Burdick et al. Journal of Neuroscience profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Burdick United States 10 1.3k 684 352 279 222 19 1.7k
Suhail Rasool United States 19 1.3k 1.0× 792 1.2× 278 0.8× 248 0.9× 371 1.7× 31 1.8k
Marianne Grant United States 18 1.2k 0.9× 713 1.0× 297 0.8× 601 2.2× 304 1.4× 42 1.9k
Natalia N. Nalivaeva Russia 28 1.5k 1.2× 1.2k 1.7× 542 1.5× 511 1.8× 298 1.3× 91 2.8k
Camilla Nilsberth Sweden 15 1.2k 0.9× 861 1.3× 324 0.9× 218 0.8× 159 0.7× 22 1.6k
Davina E. OWEN United Kingdom 20 737 0.6× 765 1.1× 246 0.7× 467 1.7× 107 0.5× 23 1.9k
Yasushi Tomidokoro Japan 23 1.1k 0.8× 549 0.8× 168 0.5× 281 1.0× 279 1.3× 44 1.5k
Joo‐Yong Lee South Korea 25 829 0.7× 759 1.1× 228 0.6× 407 1.5× 213 1.0× 37 2.2k
Erene Mina United States 6 1.2k 1.0× 705 1.0× 316 0.9× 413 1.5× 209 0.9× 8 1.6k
Lih-Fen Lue United States 15 1.8k 1.4× 786 1.1× 432 1.2× 525 1.9× 669 3.0× 16 2.4k
Neelima B. Chauhan United States 27 686 0.5× 709 1.0× 242 0.7× 644 2.3× 327 1.5× 48 2.0k

Countries citing papers authored by Daniel Burdick

Since Specialization
Citations

This map shows the geographic impact of Daniel Burdick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Burdick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Burdick more than expected).

Fields of papers citing papers by Daniel Burdick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Burdick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Burdick. The network helps show where Daniel Burdick may publish in the future.

Co-authorship network of co-authors of Daniel Burdick

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Burdick. A scholar is included among the top collaborators of Daniel Burdick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Burdick. Daniel Burdick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
LeWitt, Peter A., Aaron Ellenbogen, Daniel Burdick, et al.. (2023). Improving levodopa delivery: IPX203, a novel extended-release carbidopa-levodopa formulation. Clinical Parkinsonism & Related Disorders. 8. 100197–100197. 9 indexed citations
3.
4.
5.
Kim, Christine, Daniel Burdick, Luca Bartolini, et al.. (2020). Leading with inclusion during the COVID-19 pandemic. Neurology. 95(12). 537–542. 9 indexed citations
6.
Agarwal, Pinky, et al.. (2019). Strategizing Clinical Trial Recruitment in the Digital Age (P1.9-072). Neurology. 92(15_supplement). 1 indexed citations
7.
Kim, Hojoong M., James B. Leverenz, Daniel Burdick, et al.. (2018). Diagnostic Validation for Participants in the Washington State Parkinson Disease Registry. Parkinson s Disease. 2018. 1–6. 18 indexed citations
8.
9.
Burdick, Daniel, et al.. (2017). Management of lower urinary tract symptoms in Parkinson's disease in the neurology clinic. International Journal of Neuroscience. 127(12). 1136–1149. 11 indexed citations
10.
Burdick, Daniel, Brenna Cholerton, G. Stennis Watson, et al.. (2014). People with Parkinson's disease and normal MMSE score have a broad range of cognitive performance. Movement Disorders. 29(10). 1258–1264. 74 indexed citations
11.
Burdick, Daniel, Alida Griffith, & Pinky Agarwal. (2013). Mydriasis in a Parkinson disease patient on low‐dose carbidopa/levodopa. Movement Disorders. 28(3). 295–295. 1 indexed citations
12.
Pike, Christian J., et al.. (1993). Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state. Journal of Neuroscience. 13(4). 1676–1687. 1260 indexed citations breakdown →
13.
Knauer, Mary F., Brian Soreghan, Daniel Burdick, Joseph V. Kosmoski, & Charles Glabe. (1992). Intracellular accumulation and resistance to degradation of the Alzheimer amyloid A4/beta protein.. Proceedings of the National Academy of Sciences. 89(16). 7437–7441. 198 indexed citations
14.
Burdick, Daniel & John T. Prior. (1982). Peutz-Jeghers syndrome. A clinicopathologic study of a large family with a 27-year follow-up. Cancer. 50(10). 2139–2146. 75 indexed citations
15.
Burdick, Daniel. (1975). Rehabilitation of the breast cancer patient. Cancer. 36(S2). 645–648. 21 indexed citations
16.
Burdick, Daniel. (1968). Reorientation toward the problem of carcinoma of the breast.. PubMed. 127(1). 115–6. 1 indexed citations
17.
Burdick, Daniel, John T. Prior, & Gerard T. Scanlon. (1963). Peutz-jeghers syndrome: A clinical-pathological study of a large family with a 10-year follow-up. Cancer. 16(7). 854–867. 44 indexed citations
18.
Burdick, Daniel. (1961). Experiences with a program to achieve palliation of incurable carcinoma of the breast.. PubMed. 112. 334–42. 4 indexed citations
19.
Burdick, Daniel, et al.. (1954). Central New York sufigical society survey on breast carcinoma, 1920 to 1952. Cancer. 7(1). 47–53. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Suhail Rasool Breakdown of academic impact, for papers by Marianne Grant Breakdown of academic impact, for papers by Natalia N. Nalivaeva Breakdown of academic impact, for papers by Camilla Nilsberth Breakdown of academic impact, for papers by Davina E. OWEN Breakdown of academic impact, for papers by Yasushi Tomidokoro Breakdown of academic impact, for papers by Joo‐Yong Lee Breakdown of academic impact, for papers by Erene Mina Breakdown of academic impact, for papers by Lih-Fen Lue Breakdown of academic impact, for papers by Neelima B. Chauhan
Rankless by CCL
2026